Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data

• Published in: BMC musculoskeletal disorders Vol. 20; no. 1; pp. 174 - 9
• Main Authors: Wang, Guochun, Bi, Liqi, Li, Xiangpei, Li, Zhijun, Zhao, Dongbao, Chen, Jinwei, He, Dongyi, Wang, Chia-Ning, Wu, Tao, Dueñas, Héctor, Skljarevski, Vladimir, Yue, Li
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 22.04.2019; BioMed Central; BMC
• Subjects: Analgesics; Arthritis; Back pain; China; Chronic pain; Clinical trials; Diabetes; Diabetic neuropathy; Dosage and administration; Drug dosages; Drug therapy; Duloxetine; Fibromyalgia; Hip; Knee; Labels; Methods; Musculoskeletal diseases; Narcotics; Nonsteroidal anti-inflammatory drugs; Osteoarthritis; Pain management; Patients; Rheumatology; Risk factors; Substance abuse treatment; Suicide; Duloxetine; Osteoarthritis; China; Chronic pain

The objectives of this study were to assess the maintenance of effect of duloxetine 60 mg once-daily (QD) in Chinese patients with chronic pain due to osteoarthritis (OA) of the knee or hip and to provide additional long-term safety data. This was an open-label, extension phase of a randomized, doub...